ShuhaiberJ and
AndersonRJ.Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg2007; 31: 267–275.
2.
PrazFBorgerMALanzJ, et al. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J2025; 46: 4635–4736.
3.
OttoCMNishimuraRABonowRO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation2021; 143: e35–e71.
4.
RussoAGrigioniFAvierinosJ, et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol2008; 51: 1203–1211.
5.
BraunbergerEDelocheABerrebiA, et al. Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation2001; 104(12 suppl 1): I8–I11.
6.
ChauvaudSFuzellierJFBerrebiA, et al. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation2001; 104(12 suppl 1): I2–I5.
7.
AsopaSPatelA and
DunningJ.Is short-term anticoagulation necessary after mitral valve repair?Interact Cardiovasc Thorac Surg2006; 5: 761–765.
8.
LaskarNBaylissCDKirmaniBH, et al. Antithrombotic therapy after heart valve surgery: contemporary practice in the UK. Interdiscip Cardiovasc Thorac Surg2024; 38: ivae089.
9.
National Institute for Health and Care Excellence. Heart valve disease presenting in adults: investigation and management; NICE guideline, No. 208. London: National Institute for Health and Care Excellence (NICE), 2021.
10.
SchwannTAVeksteinAMEngelmanDT, et al. Long-term outcomes and anticoagulation in mitral valve surgery: a report from the Society of Thoracic Surgeons database. Ann Thorac Surg2023; 116: 944–953.
11.
WattTMurraySLBresciaAA, et al. Anticoagulation following mitral valve repair. J Card Surg2020; 35: 2887–2894.
12.
BrownCRSperryAECohenWG, et al. Risk of stroke and major bleeding with vitamin K antagonist use after mitral valve repair. Ann Thorac Surg2023; 115: 957–964.
13.
SantiseGNardellaSMiglianoF, et al. The HAS-BLED score is associated with major bleeding in patients after cardiac surgery. J Cardiothorac Vasc Anesth2019; 33: 1601–1606.
14.
TomsicAZhaoCSchoonesJW, et al. Oral anticoagulation versus antiplatelet treatment after mitral valve repair: a systematic review and meta-analysis. Am J Cardiol2024; 210: 58–64.
15.
Van der WallSJOlsthoornJRHeutsS, et al. Antithrombotic therapy after mitral valve repair: VKA or aspirin?J Thromb Thrombolysis2018; 46: 473–481.
16.
GbreelMIElkasabyMHHassanM, et al. Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis. BMC Cardiovasc Disord2025; 25: 628.
17.
GaoWZhangZJiaP, et al. Efficacy and safety of direct oral anticoagulants in patients after heart valve replacement or repair: a systematic review and network meta-analysis. Clin Ther2025; 47: 1061–1068.
18.
PaparellaDBelley-CoteEPMauroMD, et al. Oral anticoagulation in patients with atrial fibrillation and heart valve prosthesis: a substudy from the Left Atrial Appendage Occlusion Study (LAAOS) III trial. J Thorac Cardiovasc Surg. Epub ahead of print 8 September 2025. DOI: 10.1016/j.jtcvs.2025.08.046.
19.
MentiasASaadMMichaelM, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair. J Am Heart Assoc2022; 11: e026666.
20.
NathanASYangLGengZ, et al. Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair. Am Heart J2021; 232: 1–9.
21.
GuimarãesHPLopesRDSilvaP, et al. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med2020; 383: 2117–2126.
22.
RussoAGrigioniFAvierinosJ, et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol2008; 51: 1203–1211.
23.
DavidTEDavidCMTsangW, et al. Long-term results of mitral valve repair for regurgitation due to leaflet prolapse. J Am Coll Cardiol2019; 74: 1044–1053.
24.
DionRA.Thromboembolic complications after surgical correction of mitral regurgitation: finding a balance. J Am Coll Cardiol2008; 51: 1212–1213.
25.
MoriMGanGMahmoodSUB, et al. Variations in anticoagulation practice following bioprosthetic aortic and mitral valve replacement and repair. J Am Coll Cardiol2020; 76: 2412–2413.